Free Trial
→ Your book is inside (From Profits Run) (Ad)tc pixel Free UAMY Stock Alerts

United States Antimony (UAMY) Financials

United States Antimony logo
$9.02 -0.08 (-0.82%)
As of 01:11 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for United States Antimony

Annual Income Statements for United States Antimony

This table shows United States Antimony's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -0.89 -1.36 -1.18 0.82 -3.72 -3.34 -0.11 0.38 -6.36 -1.74 -4.35
Consolidated Net Income / (Loss)		 -0.84 -1.31 -1.13 0.87 -3.67 -3.29 -0.06 0.43 -6.35 -1.73 -4.34
Net Income / (Loss) Continuing Operations		 -0.84 -1.31 -1.13 0.87 -3.67 -3.29 -0.06 0.43 -6.35 -1.73 -4.34
Total Pre-Tax Income 		-0.84 -1.01 -1.13 0.54 -3.67 -3.29 -0.06 0.44 -6.35 -1.73 -4.34
Total Operating Income		 -0.81 -0.82 -0.96 0.55 -3.75 -3.30 -0.66 0.35 -7.07 -2.39 -8.46
Total Gross Profit		 -0.41 0.54 0.28 0.00 -0.82 0.21 0.84 2.00 -3.34 3.47 9.87
Total Revenue		 13 12 10 9.03 8.27 5.24 7.75 11 8.69 15 39
Operating Revenue		 13 12 10 9.03 8.27 5.24 7.75 11 8.69 15 39
Total Cost of Revenue		 14 11 9.95 9.03 9.08 5.03 6.91 9.05 12 11 29
Operating Cost of Revenue		 14 11 9.95 9.03 9.08 5.03 6.91 9.05 12 11 29
Total Operating Expenses		 0.40 1.35 1.24 -0.55 2.94 3.51 1.50 1.65 3.72 5.86 18
Selling, General & Admin Expense		 1.02 0.99 0.86 1.28 1.01 1.54 1.24 1.17 3.51 5.85 19
Other Operating Expenses / (Income)		 -0.62 0.36 0.37 -1.82 0.52 1.49 0.07 0.48 - 0.00 -0.47
Other Special Charges / (Income)		 - - - 0.00 1.41 0.32 - 0.00 0.22 0.01 0.05
Total Other Income / (Expense), net		 -0.03 -0.19 -0.17 -0.01 0.08 0.02 0.60 0.10 0.72 0.66 4.12
Interest & Investment Income		 0.01 0.00 0.00 - - - 0.05 0.10 0.62 0.67 0.81
Other Income / (Expense), net		 -0.04 -0.04 -0.07 0.09 0.16 0.04 0.44 -0.01 0.10 -0.01 3.31
Income Tax Expense		 0.00 0.30 0.00 -0.33 - - 0.00 0.02 0.00 0.00 0.00
Preferred Stock Dividends Declared		 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 -0.01 0.01 0.01
Basic Earnings per Share		 ($0.01) ($0.02) ($0.02) $0.01 ($0.05) ($0.05) - $0.00 ($0.06) ($0.02) ($0.04)
Weighted Average Basic Shares Outstanding		 66.21M 66.78M 67.41M 67.98M 69.00M 72.51M 102.84M 106.29M 107.55M 108.59M 123.64M
Diluted Earnings per Share		 ($0.01) ($0.02) ($0.02) $0.01 ($0.05) ($0.05) - $0.00 ($0.06) ($0.02) ($0.04)
Weighted Average Diluted Shares Outstanding		 66.21M 66.78M 67.41M 68.10M 69.00M 72.51M 102.84M 106.29M 107.55M 108.59M 123.64M
Weighted Average Basic & Diluted Shares Outstanding		 66.21M 66.78M 59.20M 82.50M 69.00M 72.51M 102.84M - - 114.63M 143.37M

Quarterly Income Statements for United States Antimony

This table shows United States Antimony's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -1.65 -3.56 -0.32 0.20 -0.73 -0.88 0.54 0.18 -4.78 -0.29 -11
Consolidated Net Income / (Loss)		 -1.64 -3.56 -0.32 0.20 -0.73 -0.88 0.55 0.18 -4.78 -0.29 -11
Net Income / (Loss) Continuing Operations		 -0.18 -6.43 -0.32 0.20 -0.73 -1.08 0.55 0.18 -4.78 -0.29 -11
Total Pre-Tax Income 		-0.18 -5.04 -0.32 0.20 -0.73 -0.67 0.55 0.18 -4.78 -0.29 -11
Total Operating Income		 -0.36 -6.88 -0.47 0.06 -0.89 -1.26 0.36 0.02 -4.92 -3.92 -7.52
Total Gross Profit		 0.26 -4.38 0.59 1.25 0.42 1.31 2.37 2.84 2.01 2.65 1.11
Total Revenue		 2.06 2.15 3.07 3.66 2.57 6.87 7.00 11 8.70 13 6.78
Operating Revenue		 2.06 2.15 3.07 3.66 2.57 6.87 7.00 11 8.70 13 6.78
Total Cost of Revenue		 1.81 6.54 2.48 2.41 2.15 5.56 4.63 7.69 6.69 10 5.67
Operating Cost of Revenue		 1.81 6.54 2.48 2.41 2.15 5.56 4.63 7.69 6.69 10 5.67
Total Operating Expenses		 0.62 0.79 1.06 1.19 1.31 2.61 2.01 2.82 6.93 6.57 8.63
Selling, General & Admin Expense		 0.62 2.26 1.04 1.19 1.33 3.09 1.01 2.82 7.41 6.51 2.75
Other Operating Expenses / (Income)		 - - - - 0.00 - 1.00 - -0.47 - 5.88
Other Special Charges / (Income)		 0.00 0.22 0.02 0.00 -0.02 0.04 -0.00 0.00 -0.01 0.06 -0.00
Total Other Income / (Expense), net		 0.18 -0.05 0.15 0.15 0.16 0.19 0.19 0.16 0.14 3.63 -3.76
Interest & Investment Income		 0.18 0.15 0.15 0.15 0.16 0.21 0.19 0.15 0.15 0.31 0.33
Other Income / (Expense), net		 0.00 -0.20 -0.00 -0.01 0.01 -0.02 -0.00 0.01 -0.01 3.32 -4.09
Other Gains / (Losses), net		 - - - - - - 0.00 - - - -0.02
Preferred Stock Dividends Declared		 0.00 - 0.00 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 0.00
Basic Earnings per Share		 $107,647,317.00 ($322,555,106.06) $0.00 $0.00 ($0.01) ($324,786,274.02) $0.00 $0.00 ($0.04) - ($0.08)
Weighted Average Basic Shares Outstanding		 107.65M 107.55M 107.91M 108.44M 108.44M 108.59M 113.70M 118.26M 123.41M 123.64M 141.61M
Diluted Earnings per Share		 $107,647,317.00 ($322,555,106.06) $0.00 $0.00 ($0.01) ($325,290,416.02) $0.00 $0.00 ($0.04) - ($0.08)
Weighted Average Diluted Shares Outstanding		 107.65M 107.55M 107.91M 108.94M 108.44M 108.59M 122.39M 127.22M 123.41M 123.64M 141.61M
Weighted Average Basic & Diluted Shares Outstanding		 107.65M 0.00 108.44M 108.44M 108.44M 114.63M 117.92M 120.72M 140.04M 143.37M 148.19M

Annual Cash Flow Statements for United States Antimony

This table details how cash moves in and out of United States Antimony's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 0.01 -0.12 0.02 0.02 0.06 0.55 24 -2.30 -7.64 6.32 12
Net Cash From Operating Activities		 0.36 0.43 0.72 -0.66 -0.01 -1.31 -2.43 -0.25 -4.75 2.22 -9.69
Net Cash From Continuing Operating Activities		 -0.06 0.38 0.54 -0.66 -0.01 -1.31 0.72 2.32 -5.23 2.24 -9.69
Net Income / (Loss) Continuing Operations		 -0.84 -1.31 -1.13 0.87 -3.67 -3.29 -0.06 0.43 -6.35 -1.73 -4.34
Consolidated Net Income / (Loss)		 -0.84 -1.31 -1.13 0.87 -3.67 -3.29 -0.06 0.43 -6.35 -1.73 -4.34
Depreciation Expense		 0.93 1.00 0.97 0.90 0.90 0.89 0.88 0.91 0.96 1.09 1.17
Non-Cash Adjustments To Reconcile Net Income		 0.07 0.11 0.21 -1.95 1.70 0.43 0.43 0.36 2.41 0.63 4.20
Changes in Operating Assets and Liabilities, net		 0.19 0.56 0.58 -0.56 1.01 0.66 -0.53 0.62 -2.25 2.26 -11
Net Cash From Investing Activities		 -1.70 -0.58 -0.37 0.90 -0.39 -0.24 -0.65 -1.79 -1.34 -0.04 -87
Net Cash From Continuing Investing Activities		 -1.70 -0.58 -0.37 0.90 -0.39 -0.24 -0.65 -1.79 -1.34 -0.04 -87
Purchase of Property, Plant & Equipment		 -1.71 -0.60 -0.37 -0.90 -0.79 -0.24 -0.65 -1.73 -1.53 -0.43 -28
Purchase of Investments		 - - - - - - 0.00 -16 - 0.00 -57
Sale of Property, Plant & Equipment		 0.01 - 0.00 0.30 0.40 - - - 0.00 0.32 0.01
Other Investing Activities, net		 0.00 0.01 - - - 0.00 -0.00 - 0.19 0.00 -2.50
Net Cash From Financing Activities		 1.36 0.03 -0.33 -0.22 0.46 2.10 24 -0.27 -1.07 4.14 109
Net Cash From Continuing Financing Activities		 1.36 0.03 -0.33 -0.22 0.46 2.10 24 -0.27 -1.07 4.14 109
Repayment of Debt		 -0.09 -0.18 -0.21 -0.38 -0.16 -0.23 -0.14 -0.06 -0.28 -0.10 -0.13
Repurchase of Common Equity		 - - - - - - 0.00 -0.20 - 0.00 -0.45
Issuance of Common Equity		 - - - 0.00 0.40 1.81 23 - 0.00 - 104
Other Financing Activities, net		 1.32 0.17 -0.15 0.02 -0.03 0.07 0.58 - - 1.48 5.85
Cash Interest Paid		 - 0.01 0.01 0.02 0.02 0.02 0.01 0.02 0.01 0.01 0.02

Quarterly Cash Flow Statements for United States Antimony

This table details how cash moves in and out of United States Antimony's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -0.51 1.44 -0.64 1.13 0.62 5.88 0.57 -13 13 12 -27
Net Cash From Operating Activities		 0.47 -4.05 0.07 0.57 0.41 1.34 -1.73 -0.63 -3.86 -3.47 -12
Net Cash From Continuing Operating Activities		 0.47 -4.53 -0.61 1.25 0.42 1.86 -1.73 -0.63 -3.86 -3.47 -12
Net Income / (Loss) Continuing Operations		 -0.18 -6.43 0.00 -0.12 -0.73 -1.08 0.55 0.18 -4.78 -0.29 -11
Consolidated Net Income / (Loss)		 -0.18 -6.43 - - -0.73 - 0.55 0.18 -4.78 -0.29 -11
Depreciation Expense		 0.09 0.71 0.11 0.11 0.12 0.75 0.28 0.28 0.28 0.33 0.41
Non-Cash Adjustments To Reconcile Net Income		 0.00 2.38 0.14 0.19 0.21 0.64 0.41 0.61 3.32 -0.14 8.87
Changes in Operating Assets and Liabilities, net		 0.56 -1.19 -0.86 1.06 0.81 1.55 -2.97 -1.70 -2.68 -3.37 -10
Net Cash From Investing Activities		 0.01 -0.00 -0.00 -0.10 0.24 -0.18 -0.86 -17 -19 -51 -13
Net Cash From Continuing Investing Activities		 -0.14 -0.00 -0.00 -0.10 0.24 -0.18 -0.86 -17 -19 -51 -13
Purchase of Property, Plant & Equipment		 -0.14 -0.19 -0.05 -0.10 -0.07 -0.21 -0.86 -6.53 -8.68 -12 -13
Acquisitions		 - - - - - - 0.00 - - - -0.10
Purchase of Investments		 - - - - - - 0.00 - -9.94 -37 0.00
Sale of Property, Plant & Equipment		 - - 0.00 - 0.31 0.00 0.00 - 0.01 0.00 0.00
Sale and/or Maturity of Investments		 - - - - - - 0.00 - - - 0.10
Net Cash From Financing Activities		 -0.02 -0.21 -0.02 -0.02 -0.03 4.21 3.17 4.11 35 67 -2.63
Net Cash From Continuing Financing Activities		 -0.02 -0.21 -0.02 -0.02 -0.03 4.21 3.17 4.11 35 67 -2.63
Repayment of Debt		 -0.02 -0.21 -0.02 -0.02 -0.03 -0.03 -0.03 -0.03 -0.03 -0.03 -0.03
Repurchase of Common Equity		 - - - - - - 0.00 - - -0.04 -4.98
Issuance of Debt		 - - - - - - 2.39 2.67 33 - 1.34
Other Financing Activities, net		 - - - - - - 0.81 - 4.43 1.37 1.04
Cash Interest Paid		 - - 0.00 0.00 0.00 - 0.00 0.00 0.01 0.00 0.00

Annual Balance Sheets for United States Antimony

This table presents United States Antimony's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 18 18 17 18 14 13 35 35 28 35 154
Total Current Assets		 2.14 1.69 1.56 1.90 1.28 1.81 24 22 14 21 55
Cash & Equivalents		 0.13 0.01 0.03 0.06 0.12 0.67 21 19 12 18 30
Short-Term Investments		 0.25 0.25 0.25 0.25 0.25 0.25 0.26 0.26 0.07 0.00 4.58
Note & Lease Receivable		 - - - - - - - - - 0.00 2.50
Accounts Receivable		 0.42 0.55 0.36 0.44 0.28 0.24 0.89 0.78 0.63 1.10 4.21
Inventories, net		 1.09 0.86 0.91 0.76 0.63 0.65 1.06 1.38 1.39 1.25 13
Prepaid Expenses		 - - - - - - 0.00 0.14 0.09 0.16 0.43
Other Current Assets		 0.24 0.02 0.00 0.40 - - - - - - 0.00
Plant, Property, & Equipment, net		 16 16 15 15 12 11 11 12 13 13 42
Total Noncurrent Assets		 0.09 0.38 0.44 0.43 0.23 0.27 0.30 0.95 0.56 1.07 57
Long-Term Investments		 0.08 0.06 0.06 0.06 0.06 0.06 - - - 0.00 56
Other Noncurrent Operating Assets		 0.02 0.31 0.37 0.37 0.17 0.21 0.30 0.95 0.56 0.97 0.38
Other Noncurrent Nonoperating Assets		 - - - - - - - - - 0.10 0.16
Total Liabilities & Shareholders' Equity		 18 18 17 18 14 13 35 35 28 35 154
Total Liabilities		 5.80 6.42 6.75 6.13 5.23 6.11 2.63 2.83 2.57 6.04 13
Total Current Liabilities		 2.43 3.38 3.93 3.52 3.98 4.48 2.07 2.22 0.90 4.01 10
Short-Term Debt		 0.31 0.56 0.74 0.89 0.25 0.15 0.01 0.09 0.03 0.13 0.14
Accounts Payable		 1.66 1.81 2.30 2.02 2.69 2.10 1.44 0.63 0.46 1.55 6.92
Accrued Expenses		 0.14 0.12 0.17 0.35 0.64 0.64 0.27 0.71 0.41 1.60 3.08
Other Current Liabilities		 0.01 0.19 0.04 0.06 0.40 0.46 0.35 - 0.00 0.63 0.03
Total Noncurrent Liabilities		 3.37 3.04 2.82 2.61 1.25 1.64 0.56 0.61 1.68 2.04 2.79
Long-Term Debt		 1.72 1.47 1.24 1.03 0.08 0.48 0.20 0.22 0.00 0.20 0.06
Asset Retirement Reserve & Litigation Obligation		 - - - - - - 0.30 0.33 1.64 1.71 2.72
Other Noncurrent Operating Liabilities		 1.65 1.57 1.58 1.59 1.17 1.16 0.06 0.06 0.04 0.13 0.01
Commitments & Contingencies		 - 0.00 0.00 0.00 0.00 - - - - 0.00 0.00
Total Equity & Noncontrolling Interests		 12 11 10 11 8.47 7.19 32 32 26 29 141
Total Preferred & Common Equity		 12 11 10 11 8.47 7.19 32 32 26 29 141
Preferred Stock		 0.00 0.00 0.00 0.03 0.03 0.03 0.03 0.03 0.01 0.01 0.01
Total Common Equity		 12 11 10 11 8.44 7.16 32 32 26 29 141
Common Stock		 37 37 37 37 38 40 65 65 65 70 187
Retained Earnings		 -24 -25 -27 -26 -29 -33 -33 -33 -39 -41 -45
Treasury Stock		 - - - - - - 0.00 -0.20 - 0.00 -0.57

Quarterly Balance Sheets for United States Antimony

This table presents United States Antimony's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 32 31 28 29 30 39 47 80 148
Total Current Assets		 18 17 14 15 15 25 18 32 48
Cash & Equivalents		 14 13 12 12 13 19 5.71 18 3.22
Short-Term Investments		 0.26 0.26 0.02 0.02 0.02 - 1.26 1.27 4.62
Note & Lease Receivable		 - - - - - - - - 2.45
Accounts Receivable		 1.31 1.39 1.06 1.39 0.79 1.97 2.54 1.90 2.51
Inventories, net		 2.35 1.88 0.65 0.46 0.97 3.99 6.81 8.41 22
Prepaid Expenses		 0.38 0.24 0.12 0.29 0.18 0.13 1.35 1.88 0.73
Other Current Assets		 - - 0.22 0.05 0.07 - - - 13
Plant, Property, & Equipment, net		 13 13 7.71 7.80 7.75 13 20 28 47
Total Noncurrent Assets		 1.22 1.31 6.29 6.52 7.00 1.09 10 20 53
Long-Term Investments		 - - - - - - 8.83 19 52
Other Noncurrent Operating Assets		 1.22 1.31 0.07 6.52 0.88 1.09 1.27 0.94 0.37
Other Noncurrent Nonoperating Assets		 - - 6.22 - 6.12 - - - 0.16
Total Liabilities & Shareholders' Equity		 32 31 28 29 30 39 47 80 148
Total Liabilities		 1.54 1.85 2.60 3.23 4.63 6.91 9.99 8.13 16
Total Current Liabilities		 0.98 1.28 0.91 1.25 2.40 4.72 8.00 6.26 13
Short-Term Debt		 0.08 0.06 0.01 0.13 0.13 0.13 0.13 0.14 0.14
Accounts Payable		 0.41 0.61 0.40 0.54 1.21 3.21 5.75 4.22 9.67
Accrued Expenses		 0.27 0.33 0.34 0.43 0.43 0.80 1.52 1.79 3.53
Other Current Liabilities		 0.22 0.28 - - 0.48 0.58 0.59 0.12 0.03
Total Noncurrent Liabilities		 0.57 0.57 1.69 1.98 2.22 2.19 2.00 1.87 2.79
Long-Term Debt		 0.18 0.18 - 0.26 0.23 0.16 0.13 0.09 0.02
Asset Retirement Reserve & Litigation Obligation		 0.34 0.34 1.12 1.14 1.16 1.73 1.75 1.77 2.75
Other Noncurrent Operating Liabilities		 0.04 0.04 0.04 0.04 0.30 0.29 0.12 0.01 0.01
Commitments & Contingencies		 - - - - - - - 0.00 0.00
Total Equity & Noncontrolling Interests		 31 29 25 26 25 33 38 72 132
Total Preferred & Common Equity		 31 29 25 26 25 33 38 72 132
Preferred Stock		 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Total Common Equity		 31 29 25 26 25 33 37 72 132
Common Stock		 65 65 65 65 65 73 78 117 195
Retained Earnings		 -34 -36 -40 -40 -40 -41 -40 -45 -57
Treasury Stock		 0.00 0.00 - - - - - -0.51 -6.37

Annual Metrics And Ratios for United States Antimony

This table displays calculated financial ratios and metrics derived from United States Antimony's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 66,316,278.00 66,866,278.00 67,488,153.00 68,227,171.00 69,661,436.00 75,949,757.00 106,117,844.00 106,373,341.00 107,647,317.00 - 140,035,604.00
DEI Adjusted Shares Outstanding		 66,316,278.00 66,866,278.00 67,488,153.00 68,227,171.00 69,661,436.00 75,949,757.00 106,117,844.00 106,373,341.00 107,647,317.00 - 140,035,604.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.01 -0.02 -0.02 0.01 -0.05 -0.04 0.00 0.00 -0.06 - -0.03
Growth Metrics		 - - - - - - - - - - -
Profitability Metrics		 - - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)		 -0.57 -0.57 -0.67 0.88 -2.63 -2.31 -0.46 0.34 -4.95 -1.67 -5.92
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - -19.37% -5.79% -4.20%
Earnings before Interest and Taxes (EBIT)		 -0.84 -0.85 -1.03 0.64 -3.59 -3.27 -0.22 0.34 -6.97 -2.40 -5.15
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 0.09 0.22 0.03 1.63 -2.64 -2.38 0.66 1.25 -6.01 -1.31 -3.98
Valuation Ratios		 - - - - - - - - - - -
Leverage & Solvency		 - - - - - - - - - - -
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -1.17 0.41 0.37 -0.08 1.98 -0.78 -4.58 -2.35 -4.88 1.25 -45
Efficiency Ratios		 - - - - - - - - - - -
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 14 13 12 13 8.37 6.84 11 14 14 11 50
Increase / (Decrease) in Invested Capital		 0.61 -0.98 -1.04 0.96 -4.60 -1.53 4.12 2.69 -0.07 -2.92 39
Book Value per Share		 $0.19 $0.17 $0.15 $0.17 $0.12 $0.09 $0.30 $0.30 $0.24 $0.26 $1.01
Tangible Book Value per Share		 $0.19 $0.17 $0.15 $0.17 $0.12 $0.09 $0.30 $0.30 $0.24 $0.26 $1.01
Total Capital		 14 13 12 13 8.80 7.82 33 32 26 29 141
Total Debt		 2.03 2.03 1.98 1.92 0.33 0.63 0.22 0.31 0.03 0.33 0.20
Total Long-Term Debt		 1.72 1.47 1.24 1.03 0.08 0.48 0.20 0.22 0.00 0.20 0.06
Net Debt		 1.57 1.71 1.64 1.55 -0.10 -0.35 -21 -19 -12 -18 -91
Capital Expenditures (CapEx)		 1.70 0.60 0.37 0.60 0.39 0.24 0.65 1.73 1.53 0.11 28
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -0.37 -1.39 -1.91 -1.03 -2.81 -3.44 -0.11 0.17 1.23 -1.47 9.63
Debt-free Net Working Capital (DFNWC)		 0.02 -1.13 -1.63 -0.72 -2.44 -2.52 22 19 13 17 45
Net Working Capital (NWC)		 -0.29 -1.69 -2.37 -1.61 -2.70 -2.67 21 19 13 17 45
Net Nonoperating Expense (NNE)		 0.27 0.74 0.46 0.01 1.05 0.97 -0.40 -0.09 1.40 0.06 -1.58
Net Nonoperating Obligations (NNO)		 1.57 1.71 1.64 1.55 -0.10 -0.35 -21 -18 -12 -18 -91
Total Depreciation and Amortization (D&A)		 0.93 1.07 1.06 0.99 0.95 0.89 0.88 0.91 0.96 1.09 1.17
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.01) ($0.02) ($0.02) $0.01 ($0.05) ($0.05) $0.00 $0.00 ($0.06) ($0.02) ($0.04)
Adjusted Weighted Average Basic Shares Outstanding		 66.32M 67.49M 59.20M 67.98M 69.00M 102.80M 106.24M 106.29M 107.55M 108.59M 123.64M
Adjusted Diluted Earnings per Share		 ($0.01) ($0.02) ($0.02) $0.01 ($0.05) ($0.05) $0.00 $0.00 ($0.06) ($0.02) ($0.04)
Adjusted Weighted Average Diluted Shares Outstanding		 66.32M 67.49M 59.20M 68.10M 69.00M 102.80M 106.24M 106.29M 107.55M 108.59M 123.64M
Adjusted Basic & Diluted Earnings per Share		 ($0.01) ($0.02) ($0.02) $0.01 ($0.05) ($0.05) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 66.21M 66.78M 67.41M 82.50M 69.00M 72.51M 102.84M 0.00 0.00 114.63M 143.37M
Normalized Net Operating Profit after Tax (NOPAT)		 -0.57 -0.57 -0.67 0.38 -1.64 -2.09 -0.46 0.34 -4.80 -1.67 -5.89
Debt Service Ratios		 - - - - - - - - - - -
Payout Ratios		 - - - - - - - - - - -

Quarterly Metrics And Ratios for United States Antimony

This table displays calculated financial ratios and metrics derived from United States Antimony's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 107,647,317.00 107,647,317.00 107,647,317.00 108,438,984.00 108,438,984.00 - 229,264,738.00 117,922,971.00 120,723,320.00 140,035,604.00 143,371,936.00
DEI Adjusted Shares Outstanding		 107,647,317.00 107,647,317.00 107,647,317.00 108,438,984.00 108,438,984.00 - 229,264,738.00 117,922,971.00 120,723,320.00 140,035,604.00 143,371,936.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.02 -0.03 0.00 0.00 -0.01 - 0.00 0.00 -0.04 0.00 -0.08
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -16.25% 52.47% 38.95% 61.71% 24.65% 219.08% 127.86% 187.34% 238.31% - -3.08%
EBITDA Growth		 -196.37% -985.90% -149.68% 256.46% -185.68% 91.52% 273.17% 84.05% -507.49% - -1,859.47%
EBIT Growth		 -1,122.81% -783.25% -170.65% 126.66% -144.93% 81.85% 174.82% -47.35% -457.04% - -3,375.31%
NOPAT Growth		 -520.94% -701.26% -226.04% 140.55% -144.97% 81.64% 208.71% -64.28% -451.86% - -1,569.88%
Net Income Growth		 -3,362.82% -362.85% 60.00% 160.27% 55.76% 75.20% 269.32% -10.47% -557.13% - -2,166.60%
EPS Growth		 358,824,390,100.00% -3,225,551,060,700.00% -100.00% -100.00% -100.00% -0.85% 0.00% 0.00% -300.00% - 0.00%
Operating Cash Flow Growth		 165.46% -1,389.49% 107.07% 327.85% -13.01% 132.96% -2,759.34% -210.91% -1,039.62% - -597.38%
Free Cash Flow Firm Growth		 -32.80% -44.30% 300.65% 152.32% 353.80% 142.89% -177.60% -383.12% -451.68% - -991.64%
Invested Capital Growth		 23.55% -0.53% -49.42% -15.45% -56.24% -21.50% 77.13% 52.98% 372.19% - 410.04%
Revenue Q/Q Growth		 -8.90% 4.37% 42.65% 19.23% -29.78% 183.84% 1.87% 50.36% -17.32% - -47.94%
EBITDA Q/Q Growth		 -153.60% -2,278.06% 94.23% 145.00% -563.05% 25.11% 217.80% -52.17% -1,628.37% - -4,005.14%
EBIT Q/Q Growth		 -89.42% -1,860.25% 93.32% 110.74% -1,840.22% -52.91% 127.56% -92.44% -18,510.54% - -1,834.56%
NOPAT Q/Q Growth		 -84.32% -1,791.84% 93.16% 117.01% -1,213.62% -49.51% 140.48% -94.41% -17,304.12% - -91.78%
Net Income Q/Q Growth		 -388.77% -116.49% 90.93% 162.83% -458.75% -21.36% 161.90% -66.78% -2,733.20% - -3,836.67%
EPS Q/Q Growth		 0.00% -399.64% 100.00% 0.00% 0.00% -399.98% 100.00% 0.00% 0.00% - 0.00%
Operating Cash Flow Q/Q Growth		 290.31% -957.70% 101.60% 770.31% -27.34% 198.03% -229.41% 63.70% -515.54% - -247.51%
Free Cash Flow Firm Q/Q Growth		 34.98% -42.45% 256.31% -63.86% 215.37% -76.02% -382.83% -31.86% -291.74% - -50.92%
Invested Capital Q/Q Growth		 -4.98% -15.89% -41.62% 81.19% -50.82% 50.88% 31.75% 56.49% 51.79% - 44.24%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 12.52% -203.59% 19.19% 34.13% 16.48% 19.06% 33.88% 26.96% 23.14% - 16.35%
EBITDA Margin		 -12.99% -295.95% -11.96% 4.51% -29.77% -7.86% 9.09% 2.89% -53.45% - -165.04%
Operating Margin		 -17.63% -319.52% -15.31% 1.53% -34.64% -18.39% 5.11% 0.19% -56.51% - -110.81%
EBIT Margin		 -17.52% -328.99% -15.42% 1.39% -34.42% -18.71% 5.06% 0.25% -56.67% - -171.09%
Profit (Net Income) Margin		 -79.69% -165.32% -10.51% 5.54% -28.28% -12.85% 7.81% 1.73% -54.94% - -166.49%
Tax Burden Percent		 889.97% 70.64% 100.00% 100.00% 100.00% 132.01% 100.00% 100.00% 100.00% - 100.14%
Interest Burden Percent		 51.12% 71.14% 68.15% 398.64% 82.18% 52.02% 154.23% 677.82% 96.95% - 97.17%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Return on Invested Capital (ROIC)		 -6.72% -142.83% -8.68% 1.07% -23.95% -15.87% 8.78% 0.27% -62.36% - -70.71%
ROIC Less NNEP Spread (ROIC-NNEP)		 1.58% -151.16% -8.72% -0.10% -23.28% -15.88% 7.74% -0.93% -57.62% - -55.41%
Return on Net Nonoperating Assets (RNNOA)		 -0.84% 79.45% 5.08% 0.05% 13.32% 8.77% -4.81% 0.40% 33.58% - 26.55%
Return on Equity (ROE)		 -7.56% -63.38% -3.60% 1.11% -10.64% -7.10% 3.98% 0.67% -28.78% - -44.16%
Cash Return on Invested Capital (CROIC)		 -26.08% -35.82% 18.71% -17.46% 28.85% 10.28% -65.62% -48.04% -149.58% - -161.13%
Operating Return on Assets (OROA)		 -4.20% -91.09% -4.84% 0.50% -13.00% -8.91% 2.83% 0.17% -32.93% - -71.23%
Return on Assets (ROA)		 -19.09% -45.77% -3.30% 1.98% -10.68% -6.12% 4.36% 1.16% -31.93% - -69.32%
Return on Common Equity (ROCE)		 -7.56% -63.34% -3.60% 1.11% -10.63% -7.10% 3.98% 0.67% -28.77% - -44.15%
Return on Equity Simple (ROE_SIMPLE)		 -12.23% 0.00% -23.08% 0.00% 0.00% 0.00% -2.64% 0.00% 0.00% - 0.00%
Net Operating Profit after Tax (NOPAT)		 -0.25 -4.82 -0.33 0.06 -0.62 -0.88 0.36 0.02 -3.44 -2.74 -5.26
NOPAT Margin		 -12.34% -223.66% -10.72% 1.53% -24.25% -12.87% 5.11% 0.19% -39.55% - -77.56%
Net Nonoperating Expense Percent (NNEP)		 -8.30% 8.33% 0.04% 1.17% -0.67% 0.01% 1.05% 1.20% -4.74% - -15.30%
Return On Investment Capital (ROIC_SIMPLE)		 - -18.85% -1.30% 0.21% -2.45% -3.06% 1.09% 0.05% -4.78% -1.94% -3.98%
Cost of Revenue to Revenue		 87.48% 303.59% 80.81% 65.87% 83.52% 80.94% 66.12% 73.04% 76.86% - 83.65%
SG&A Expenses to Revenue		 30.15% 104.86% 33.93% 32.60% 51.75% 44.97% 28.77% 26.77% 85.14% - 40.52%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Operating Expenses to Revenue		 30.15% 36.58% 34.50% 32.60% 51.12% 37.95% 28.77% 26.77% 79.64% - 127.16%
Earnings before Interest and Taxes (EBIT)		 -0.36 -7.09 -0.47 0.05 -0.89 -1.29 0.35 0.03 -4.93 -0.60 -12
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -0.27 -6.37 -0.37 0.17 -0.77 -0.54 0.64 0.30 -4.65 -0.27 -11
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.37 1.05 1.06 1.42 3.29 6.71 7.74 6.86 10.43 - 9.49
Price to Tangible Book Value (P/TBV)		 1.37 1.05 1.06 1.42 3.29 6.71 7.74 6.86 10.43 - 9.49
Price to Revenue (P/Rev)		 4.99 3.08 2.82 3.33 7.22 12.85 13.37 9.99 23.49 - 32.06
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Enterprise Value to Invested Capital (EV/IC)		 1.66 1.10 1.89 1.70 9.93 16.33 16.64 10.99 21.29 - 16.64
Enterprise Value to Revenue (EV/Rev)		 3.37 1.71 1.57 2.23 6.12 11.65 12.38 9.39 22.29 - 30.52
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 78.37 548.49 0.00 0.00 - 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 6.78 0.00 20.95 139.66 0.00 0.00 0.00 - 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.01 0.00 0.00 0.02 0.01 0.01 0.01 0.01 0.00 - 0.00
Long-Term Debt to Equity		 0.01 0.00 0.00 0.01 0.01 0.01 0.01 0.00 0.00 - 0.00
Financial Leverage		 -0.53 -0.53 -0.58 -0.44 -0.57 -0.55 -0.62 -0.43 -0.58 - -0.48
Leverage Ratio		 1.06 1.09 1.08 1.08 1.12 1.16 1.16 1.21 1.13 - 1.14
Compound Leverage Factor		 0.54 0.78 0.73 4.32 0.92 0.60 1.80 8.20 1.10 - 1.11
Debt to Total Capital		 0.83% 0.11% 0.03% 1.50% 1.41% 1.13% 0.90% 0.69% 0.32% - 0.12%
Short-Term Debt to Total Capital		 0.21% 0.11% 0.03% 0.50% 0.51% 0.46% 0.41% 0.36% 0.19% - 0.10%
Long-Term Debt to Total Capital		 0.61% 0.00% 0.00% 1.00% 0.90% 0.68% 0.49% 0.34% 0.13% - 0.02%
Preferred Equity to Total Capital		 0.03% 0.04% 0.04% 0.04% 0.04% 0.03% 0.03% 0.02% 0.01% - 0.01%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Common Equity to Total Capital		 99.14% 99.85% 99.94% 98.46% 98.55% 98.84% 99.07% 99.28% 99.67% - 99.87%
Debt to EBITDA		 -1.10 0.00 0.00 -0.06 -0.05 -0.25 -0.95 -1.54 -0.06 - -0.01
Net Debt to EBITDA		 58.57 1.99 1.68 1.76 1.72 13.66 59.96 91.16 9.47 - 3.80
Long-Term Debt to EBITDA		 -0.81 0.00 0.00 -0.04 -0.03 -0.15 -0.52 -0.75 -0.02 - 0.00
Debt to NOPAT		 -0.33 -0.01 0.00 -0.07 -0.06 -0.20 -0.27 -0.23 -0.06 - -0.01
Net Debt to NOPAT		 17.66 2.41 2.16 2.24 2.20 10.72 16.96 13.88 9.75 - 5.26
Long-Term Debt to NOPAT		 -0.25 0.00 0.00 -0.05 -0.04 -0.12 -0.15 -0.11 -0.02 - 0.00
Altman Z-Score		 12.10 4.32 5.07 5.80 9.63 18.28 21.59 15.03 55.02 - 46.24
Noncontrolling Interest Sharing Ratio		 0.06% 0.06% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.02% - 0.01%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 12.99 15.68 15.46 11.67 6.24 5.16 5.26 2.21 5.08 - 3.62
Quick Ratio		 11.34 14.04 14.37 11.03 5.73 4.82 4.39 1.19 3.43 - 0.96
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -3.33 -4.75 7.42 2.68 8.45 2.04 -5.76 -7.59 -30 -42 -63
Operating Cash Flow to CapEx		 333.20% -2,119.63% 123.36% 577.44% 0.00% 648.56% -200.61% -9.61% -44.58% - -95.87%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.24 0.28 0.31 0.36 0.38 0.48 0.56 0.67 0.58 - 0.42
Accounts Receivable Turnover		 5.60 12.33 6.92 8.11 10.50 16.77 12.45 13.07 23.69 - 17.41
Inventory Turnover		 5.33 8.72 11.23 9.41 9.55 8.72 5.86 5.19 5.00 - 2.34
Fixed Asset Turnover		 0.66 0.68 0.94 1.05 1.11 1.13 1.78 1.87 1.78 - 1.30
Accounts Payable Turnover		 12.31 22.17 20.51 27.83 14.94 11.46 7.54 6.01 8.63 - 4.73
Days Sales Outstanding (DSO)		 65.20 29.59 52.76 45.02 34.75 21.77 29.32 27.93 15.41 - 20.97
Days Inventory Outstanding (DIO)		 68.47 41.86 32.51 38.77 38.21 41.87 62.24 70.28 73.06 - 156.04
Days Payable Outstanding (DPO)		 29.64 16.46 17.80 13.11 24.44 31.86 48.38 60.77 42.30 - 77.24
Cash Conversion Cycle (CCC)		 104.02 55.00 67.47 70.68 48.51 31.78 43.19 37.43 46.17 - 99.77
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 16 14 7.93 14 7.06 11 14 22 33 50 72
Invested Capital Turnover		 0.54 0.64 0.81 0.70 0.99 1.23 1.72 1.42 1.58 - 0.91
Increase / (Decrease) in Invested Capital		 3.08 -0.07 -7.75 -2.62 -9.08 -2.92 6.11 7.61 26 39 58
Enterprise Value (EV)		 27 15 15 24 70 174 234 242 710 - 1,192
Market Capitalization		 40 27 27 36 83 192 252 257 748 - 1,252
Book Value per Share		 $0.27 $0.24 $0.24 $0.24 $0.23 $0.26 $0.28 $0.32 $0.59 $1.01 $0.92
Tangible Book Value per Share		 $0.27 $0.24 $0.24 $0.24 $0.23 $0.26 $0.28 $0.32 $0.59 $1.01 $0.92
Total Capital		 29 26 25 26 25 29 33 38 72 141 132
Total Debt		 0.24 0.03 0.01 0.39 0.36 0.33 0.30 0.26 0.23 0.20 0.16
Total Long-Term Debt		 0.18 0.00 0.00 0.26 0.23 0.20 0.16 0.13 0.09 0.06 0.02
Net Debt		 -13 -12 -12 -12 -13 -18 -19 -16 -38 -91 -60
Capital Expenditures (CapEx)		 0.14 0.19 0.05 0.10 -0.24 0.21 0.86 6.53 8.67 12 13
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 2.23 1.23 1.14 1.08 -0.26 -1.47 1.41 2.85 5.93 9.63 27
Debt-free Net Working Capital (DFNWC)		 15 13 13 13 13 17 20 9.81 26 45 35
Net Working Capital (NWC)		 15 13 13 13 13 17 20 9.68 26 45 35
Net Nonoperating Expense (NNE)		 1.39 -1.26 -0.01 -0.15 0.10 -0.00 -0.19 -0.16 1.34 -2.46 6.03
Net Nonoperating Obligations (NNO)		 -13 -12 -17 -11 -18 -18 -19 -16 -38 -91 -60
Total Depreciation and Amortization (D&A)		 0.09 0.71 0.11 0.11 0.12 0.75 0.28 0.28 0.28 0.33 0.41
Debt-free, Cash-free Net Working Capital to Revenue		 28.03% 14.20% 11.97% 9.82% -2.30% -9.82% 7.46% 11.06% 18.62% - 70.03%
Debt-free Net Working Capital to Revenue		 193.80% 151.93% 137.19% 123.17% 111.06% 112.49% 107.36% 38.15% 80.58% - 90.11%
Net Working Capital to Revenue		 193.02% 151.60% 137.11% 121.98% 109.91% 111.61% 106.65% 37.62% 80.16% - 89.75%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.02) ($322,555,106.06) $107,908,306.00 $108,438,984.00 $108,438,984.00 ($324,786,274.02) $0.00 $0.00 ($0.04) $0.00 ($0.08)
Adjusted Weighted Average Basic Shares Outstanding		 106.29M 107.55M 108.44M 108.44M 108.44M 108.59M 113.70M 118.26M 123.41M 123.64M 141.61M
Adjusted Diluted Earnings per Share		 ($0.02) ($322,555,106.06) $107,908,306.00 $108,943,126.00 $108,438,984.00 ($325,290,416.02) $0.00 $0.00 ($0.04) $0.00 ($0.08)
Adjusted Weighted Average Diluted Shares Outstanding		 106.29M 107.55M 108.44M 108.44M 108.44M 108.59M 122.30M 127.22M 123.41M 123.64M 141.61M
Adjusted Basic & Diluted Earnings per Share		 ($0.02) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 107.65M 0.00 108.44M 108.44M 108.44M 114.63M 117.92M 120.72M 140.04M 143.37M 148.19M
Normalized Net Operating Profit after Tax (NOPAT)		 -0.25 -4.66 -0.32 0.04 -0.64 -0.85 0.25 0.01 -3.45 -2.70 -5.26
Normalized NOPAT Margin		 -12.34% -216.58% -10.32% 1.07% -24.69% -12.41% 3.57% 0.13% -39.62% - -77.58%
Pre Tax Income Margin		 -8.95% -234.03% -10.51% 5.54% -28.28% -9.73% 7.81% 1.73% -54.94% - -166.25%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% -12.41% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Augmented Payout Ratio		 0.00% -12.41% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - -33.57%

Financials Breakdown Chart

Key Financial Trends

Here are the key trends for United States Antimony (NYSE: UAMY) based on the latest four years of quarterly statements. The bullets focus on what could matter to retail investors, ordered with positives first, then neutral, then negatives.

  • Revenue growth: Q4 2025 operating revenue of $13.03 million represents substantial year‑over‑year growth from Q4 2024’s $6.87 million, signaling improved top‑line momentum.
  • Gross margin stability/strength: Q4 2025 gross profit of $2.65 million on $13.03 million revenue yields a margin around 20%, modestly higher than roughly 19% in Q4 2024, indicating improved cost efficiency.
  • Healthy near‑term liquidity: As of the latest balance sheet, total current assets (~$31.80M) vs total current liabilities (~$6.26M) imply a solid current ratio near 5x, supporting liquidity for operations and investment needs.
  • Strong equity cushion: The company shows a large equity base (Total Common Equity around $71.7M–$71.9M) with relatively small liabilities (Total Liabilities around $8.1M in latest period), indicating a robust balance sheet and low leverage risk.
  • Financing activity boosting liquidity: Net cash from financing activities was about $67.1 million in Q4 2025, aided by debt/equity actions, which provides a liquidity runway but is not tied to current operating profitability.
  • Moderate near‑term debt load: Long‑term debt remains very small (around $93k in the latest quarter), suggesting limited near‑term debt service obligations.
  • Significant investing activity: Net cash used in continuing investing activities was roughly $51.4 million in Q4 2025, reflecting sizable capex and investments that could lay the groundwork for future growth (inventory of cash outflow rather than income).
  • Net income remains negative: Net income attributable to common shareholders was -$0.289 million in Q4 2025, with a prior heavy loss of -$4.78 million in Q3 2025, highlighting ongoing profitability challenges.
  • Operating cash flow pressure: Net cash from continuing operating activities in Q4 2025 was -$3.47 million, signaling cash burn from core operations despite revenue growth.
05/29/26 10:36 AM ETAI Generated. May Contain Errors.

United States Antimony Financials - Frequently Asked Questions

According to the most recent income statement we have on file, United States Antimony's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

United States Antimony's net income appears to be on an upward trend, with a most recent value of -$4.34 million in 2025, rising from -$838.53 thousand in 2015. The previous period was -$1.73 million in 2024. View United States Antimony's forecast to see where analysts expect United States Antimony to go next.

United States Antimony's total operating income in 2025 was -$8.46 million, based on the following breakdown:
  • Total Gross Profit: $9.87 million
  • Total Operating Expenses: $18.33 million

Over the last 10 years, United States Antimony's total revenue changed from $13.11 million in 2015 to $39.26 million in 2025, a change of 199.5%.

United States Antimony's total liabilities were at $12.97 million at the end of 2025, a 114.7% increase from 2024, and a 123.6% increase since 2015.

In the past 10 years, United States Antimony's cash and equivalents has ranged from $10.06 thousand in 2016 to $30.49 million in 2025, and is currently $30.49 million as of their latest financial filing in 2025.

Over the last 10 years, United States Antimony's book value per share changed from 0.19 in 2015 to 1.01 in 2025, a change of 435.7%.


Related Companies

Financial statements for NYSE:UAMY last updated on 5/19/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel